GSK Wary Of Flonase Generic Surprise; Asks FDA For Notice

GlaxoSmithKline is asking FDA for a three-day stay of action once the agency notifies the company of its decision to grant final approval for generic versions of its nasal steroids Flonase and Beconase AQ